Paraneoplastic pemphigus with eosinophilic spongiosis and autoantibodies against desmocollins 2 and 3

Clinical and Experimental Dermatology

Volumn 39, Issue 3, 2014, Pages 323-326

  Gallo, E ^a   Garcia Martin P ^a   Fraga, J ^a   Teye, K ^b   Koga, H ^b   Hashimoto, T ^b   Garcia Diez A ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BENDAMUSTINE; CORTICOSTEROID; DESMOCOLLIN; DESMOCOLLIN 2; DESMOCOLLIN 3; DESMOGLEIN; ENVOPLAKIN; IMMUNOGLOBULIN G ANTIBODY; PERIPLAKIN; PREDNISONE; UNCLASSIFIED DRUG; AUTOANTIBODY; DSC2 PROTEIN, HUMAN; DSC3 PROTEIN, HUMAN;

ACANTHOLYSIS; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CELL SURFACE; DERMATITIS; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHIL SPONGIOSIS; EROSION; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INGUINAL REGION; KERATINOCYTE; MOUTH DISEASE; NONHODGKIN LYMPHOMA; ORAL EROSION; PARANEOPLASTIC PEMPHIGUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SINGLE DRUG DOSE; SKIN DEFECT; SKIN DISEASE; STEVENS JOHNSON SYNDROME; TREATMENT DURATION; VERY ELDERLY; BULLOUS PEMPHIGOID; EOSINOPHILIA; IMMUNOLOGY; PARANEOPLASTIC SYNDROME; PATHOLOGY; EOSINOPHILIC SPONGIOSIS; EXOCYTOSIS; HUMAN TISSUE; PRURITUS; RELAPSE; SKIN BIOPSY;

AGED, 80 AND OVER; AUTOANTIBODIES; DESMOCOLLINS; EOSINOPHILIA; FEMALE; HUMANS; PARANEOPLASTIC SYNDROMES; PEMPHIGOID, BULLOUS;

EID: 84898941424     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12296     Document Type: Article

References (10)

1. Frew JW, Murrell DF,. Paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome): clinical presentations and pathogenesis. Dermatol Clin 2011; 29: 419-25.
2. Zimmermann J, Bahmer F, Rose C, et al,. Clinical and immunopathological spectrum of paraneoplastic pemphigus. J Dtsch Dermatol Ges 2010; 8: 598-606.
3. Joly P, Richard C, Gilbert D, et al,. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000; 43: 619-26.
4. Billet SE, Grando SA, Pittelkow MR,. Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 2006; 36: 617-30. (Pubitemid 44768931)
5. Nguyen VT, Ndoye A, Bassler KD, et al,. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome. Arch Dermatol 2001; 137: 193-206. (Pubitemid 32163671)
6. Preisz K, Horváth A, Sárdy M, et al,. Exacerbation of paraneoplastic pemphigus by cyclophosphamide treatment: detecton of novel autoantigens and bronchial autoantibodies. Br J Dermatol 2004; 150: 1018-24. (Pubitemid 38903540)
7. Brandt O, Rafei D, Podstawa E, et al,. Differential IgG recognition of desmoglein 3 by paraneoplastic pemphigus and pemphigus vulgaris sera. J Invest Dermatol 2012; 132: 1738-41.
8. Müller R, Heber B, Hashimoto T, et al,. Autoantibodies against desmocollins in European patients with pemphigus. Clin Exp Dermatol 2009; 34: 898-903.
9. Den Z, Cheng X, Merched-Sauvage M, Koch PJ,. Desmocollin 3 is required for preimplantation development of the mouse embryo. J Cell Sci 2006; 119: 482-9.
10. Machado-Pinto J, McCalmont TH, Golitz L,. Eosinophilic and neutophilic spongiosis: clues to the diagnosis of immunobullous diseases and other inflammatory disorders. Sem Cutan Med Surg 1996; 15: 308-16. (Pubitemid 27197969)